Vemurafenib in Langerhans cell histiocytosis: report of a pediatric patient and review of the literature-Reference-Cited by-同舟云学术

Vemurafenib in Langerhans cell histiocytosis: report of a pediatric patient and review of the literature

Published:2018-04-24 Issue:31 Volume:9 Page:22236-22240
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Heisig Anne¹,Sörensen Jan²,Zimmermann Stefanie-Yvonne¹,Schöning Stefan¹,Schwabe Dirk¹,Kvasnicka Hans-Michael³,Schwentner Raphaela⁴,Hutter Caroline⁴,Lehrnbecher Thomas¹

Affiliation:

1. Division of Pediatric Hematology and Oncology, Hospital for Children and Adolescents, Johann Wolfgang Goethe-University, Frankfurt, Germany

2. Division of Stem Cell Transplantation and Immunology, Hospital for Children and Adolescents, Johann Wolfgang Goethe-University, Frankfurt, Germany

3. Institute of Pathology, Johann Wolfgang Goethe-University, Frankfurt, Germany

4. St. Anna Kinderspital, Vienna, Austria

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted Therapy With Vemurafenib in Brazilian Children With Refractory Langerhans Cell Histiocytosis: Two Case Reports and Review of Literature;Cancer Reports;2024-08

2. Molecular Mutations in Histiocytosis: A Comprehensive Survey of Genetic Alterations;Molecular Biotechnology;2024-02-20

3. The use of BRAF-inhibitors as monotherapy and in combination with cytosine arabinoside and 2-chloro-2’deoxyadenosine in pediatric patients with different forms of Langerhans cell histiocytosis;Russian Journal of Pediatric Hematology and Oncology;2024-01-16

4. Vemurafenib combined with cladribine and cytarabine results in durable remission of pediatric BRAF V600E–positive LCH;Blood Advances;2023-09-13

5. Langerhans cell histiocytosis as a clonal disease of mononuclear phagocyte system;Almanac of Clinical Medicine;2023-02-09